Transcription of Annex 4 - WHO
{{id}} {{{paragraph}}}
Example: stock market
Annex 4 - WHO
153 Annex 4 Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administrationIntroduction 156 General considerations 156 Part A. Manufacturing recommendations Definitions International name and proper name Descriptive definition International standards Terminology Background on influenza vaccine (human, live attenuated) production General manufacturing recommendations Procedures and facilities Eggs and cell cultures Control of source materials Choice of vaccine strain Substrate for virus propagation Master cell bank and manufacturer's working cell bank Cell culture medium Virus strains Control of vaccine pr
154 WHO Technical Report Series No. 977, 2013 WHO Expert Committee on Biological Standardization Sixtieth report A.12 Stability 193 A.12.1 Stability testing 193 A.12.2 Storage conditions 194 A.12.3 Expiry date 194 Part B. Nonclinical evaluation of new influenza vaccines
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Defining and Implementing Standards for Lecture, Technical standards, Defining and Implementing Standards for Lecture Room, CIM Definition Standards, Committee, Standards, Technical regulations, Local, Technical, The value of audit, Blood Banks and Transfusion, Blood Banks and Transfusion Services, 29th edition Summary, Blood Banks and Transfusion Services